Kairos Pharma Ltd
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company based in Los Angeles, CA, focused on developing innovative therapies to overcome cancer drug resistance and reverse cancer-induced immunosuppression. The company's lead drug, ENV105, targets the CD105 protein on cancer cells, aiming to restore sensitivity to existing treatments for prostate and lung cancers.
Committed to advancing cancer care, Kairos Pharma leverages its proprietary technologies to enhance T-cell responses against tumors and is actively conducting clinical trials across multiple cancer types. With a strong emphasis on research and strategic partnerships with major medical centers, the company is poised to make significant contributions to oncology and improve patient outcomes.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.